Noven To Present at Upcoming Investor Conferences

-- Noven Pharmaceuticals, Inc. (NASDAQ: NOVN) today announced that it is scheduled to present at two upcoming investor conferences.

Robert C. Strauss, Noven’s President, CEO & Chairman, will provide an update on Noven's business and prospects at the FTN Midwest Securities Health Care Conference in New York on Wednesday, June 7, 2006, at 1:55 p.m. Eastern Time. Mr. Strauss will also present at the Pacific Growth Equities Life Sciences Growth Conference in San Francisco on Monday, June 12, 2006, at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time). Both presentations will be webcast live at, and rebroadcasts will be available for at least two weeks at the same site.

Noven Pharmaceuticals, Inc., headquartered in Miami, Florida, is a leading developer of advanced transdermal drug delivery technologies and prescription transdermal products. Noven’s prescription patches are approved in over 30 countries, and a range of new patches are being investigated and developed in collaboration with Novartis Pharma AG, Shire plc, P&G Pharmaceuticals, Endo Pharmaceuticals Inc. and others. Noven is committed to expanding the universe of available transdermal therapies for the benefit of patients, partners and shareholders. See for additional information.

Alina Bowman
Investor Relations Coordinator